Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 22 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 8183344

    Inactivation resistant factor VIII

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 22, 2012 · Expires May 17, 2032

    granted
  2. US 8163893

    Pseudotyped retroviral vectors and methods of use thereof

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  3. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  4. US 8148343

    Tumor suppressor factor

    Molecular Discover Systems · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  5. US 8148107

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  6. US 8143378

    Polymer factor VIII moiety conjugates

    Nektar Therapeutics · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  7. US 8137960

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  8. US 8138140

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Northwestern University · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  9. US 8138312

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  10. US 8133859

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  11. US 8133865

    von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  12. US 8133915

    Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  13. US 8133977

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  14. US 8123541

    Electrical connector with expanded cover

    Hon Hai Precision Ind. Co., Ltd. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  15. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  16. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  17. US 8071323

    Human monoclonal antibodies that bind human insulin like growth factors and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  18. US 8058403

    Antibodies to stromal cell-derived factor-1 polypeptides

    Five Prime Therapeutics, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  19. US 8058226

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  20. US 8003692

    Methods and compositions to inhibit edema factor and adenylyl cyclase

    The Board of Regents of the University of Texas System · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted
  21. US 7999082

    Anti-factor B antibodies

    The Regents of the University of Colorado · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted
  22. US 7988967

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted
  23. US 7964576

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  24. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted